Grant: Discovery Grants Program - Individual
McMaster University
$29,000.00
Application of signal processing in neuroscience
FY 2010-11
Summary
This proposal develops a fundamental thrust on the interface between neurological science and signal processing and biomedical engineering, in that we propose the development of new methods in machine learning (ML) for application to problems in neuro-science. One area of application is in the field of psychiatry, with specific attention to the treatment of depression. We also propose using ML methods to offer new insight in the broader framework of neuro-science.
With respect to the psychiatry application, major depressive disorder (MDD) is a serious and debilitating psychological condition. It is not known a priori to which type of the many available anti-depressant medications a particular patient may respond. Thus, in prescribing a treatment for MDD, the psychiatrist must by necessity resort to a trial-and-error procedure. This can result in long delays before remission, with attendant suffering on the part of the patient. The applicant and his colleagues have developed a preliminary ML-based procedure that can predict the response of a particular patient to a medication using only the patient's electroencephalogram (EEG) obtained before treatment begins. This enables prescription of an effective treatment immediately. However, new ML methods with significantly improved performance must be developed before the full potential of this capability is realized. That is the first objective of this proposal.
We have previously demonstrated that certain neurological conditions such as MDD, schizophrenia, epilepsy, tinnitus, etc. can be identified using ML methods from the EEG. An additional objective is to collaborate with neuro-scientists to determine whether the relevant features extracted from the EEGs of subjects afflicted with these conditions can be used as clues to gain further insight into the pathology of these disorders.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
6567-2010
Name nom
Reilly, James
Department département
Electrical and Computer Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Application of signal processing in neuroscience
Keyword
NSERC
Application summary
This proposal develops a fundamental thrust on the interface between neurological science and signal processing and biomedical engineering, in that we propose the development of new methods in machine learning (ML) for application to problems in neuro-science. One area of application is in the field of psychiatry, with specific attention to the treatment of depression. We also propose using ML methods to offer new insight in the broader framework of neuro-science.
With respect to the psychiatry application, major depressive disorder (MDD) is a serious and debilitating psychological condition. It is not known a priori to which type of the many available anti-depressant medications a particular patient may respond. Thus, in prescribing a treatment for MDD, the psychiatrist must by necessity resort to a trial-and-error procedure. This can result in long delays before remission, with attendant suffering on the part of the patient. The applicant and his colleagues have developed a preliminary ML-based procedure that can predict the response of a particular patient to a medication using only the patient's electroencephalogram (EEG) obtained before treatment begins. This enables prescription of an effective treatment immediately. However, new ML methods with significantly improved performance must be developed before the full potential of this capability is realized. That is the first objective of this proposal.
We have previously demonstrated that certain neurological conditions such as MDD, schizophrenia, epilepsy, tinnitus, etc. can be identified using ML methods from the EEG. An additional objective is to collaborate with neuro-scientists to determine whether the relevant features extracted from the EEGs of subjects afflicted with these conditions can be used as clues to gain further insight into the pathology of these disorders.